Literature DB >> 14526148

The Lundh test and faecal elastase 1 determination in chronic pancreatitis: a comparative study.

C Gredal1, L G Madsen, S Larsen.   

Abstract

BACKGROUND/AIM: A reduced exocrine pancreatic function supports the diagnosis of chronic pancreatitis (CP) in symptomatic patients. A sensitive test for a reduced exocrine function is decisive, especially when morphological changes are missing. The aim of this study was to compare the indirect faecal elastase 1 (FE-1) test with the direct Lundh test in patients with and without definite diagnostic imaging findings.
METHODS: Eighty-nine patients with clinical signs suggesting CP or having an established diagnosis of CP had a Lundh test and an estimation of FE-1 performed. All patients underwent abdominal ultrasonography and/or computed tomography.
RESULTS: A significant correlation (r = 0.70, p < 0.02) was found between FE-1 and meal-stimulated intraduodenal lipase. Using the Lundh test as reference, the predictive values of a positive and negative FE-1 test were for all patients investigated 81 and 73%, respectively. Patients with equivocal imaging findings had lower predictive values (positive predictive value 57%; negative predictive value 71%) as compared with patients with moderate or marked imaging findings (positive predictive value 84%; negative predictive value 78%). Fair to moderate chance-corrected agreement was found between Lundh test and FE-1 concentration.
CONCLUSIONS: In patient with imaging findings suggesting CP, FE-1 determination is a highly sensitive test for exocrine pancreatic function, but in patients with equivocal imaging findings, the predictive power of FE-1 limits the test to serve as a reliable diagnostic tool. Copyright 2003 S. Karger AG, Basel and IAP

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14526148     DOI: 10.1159/000073654

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  4 in total

1.  Analysis of pancreatic elastase-1 concentrations in duodenal aspirates from healthy subjects and patients with chronic pancreatitis.

Authors:  Tyler Stevens; Darwin Conwell; Gregory Zuccaro; Frederick Van Lente; Farah Khandwala; Patrick Hanaway; John J Vargo; John A Dumot
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

2.  Now that fecal elastase is available in the United States, should clinicians start using it?

Authors:  Paul G Lankisch
Journal:  Curr Gastroenterol Rep       Date:  2004-04

3.  Using faecal elastase-1 to screen for chronic pancreatitis in patients admitted with acute pancreatitis.

Authors:  R C Turner; R McDermott
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 4.  Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines.

Authors:  Mary E Phillips; Andrew D Hopper; John S Leeds; Keith J Roberts; Laura McGeeney; Sinead N Duggan; Rajesh Kumar
Journal:  BMJ Open Gastroenterol       Date:  2021-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.